Weaver C. Barksdale & Associates, Inc. / MRK
Weaver C. Barksdale & Associates, Inc.’s Merck & Co Inc Position
Does Weaver C. Barksdale & Associates, Inc. own Merck & Co Inc (MRK)? Yes — 11.0K shares worth $1M (+1.26% of its 13F portfolio) as of Q1 2026, down from 11.4K shares the prior filed quarter.
Position Value
$1M
Q1 2026
Shares
11.0K
% of Portfolio
+1.26%
Quarters Held
18
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 11.0K | $1M | +1.26% |
| Q4 2025 | 11.4K | $1M | +1.25% |
| Q3 2025 | 13.3K | $1M | +1.08% |
| Q2 2025 | 14.6K | $1M | +1.11% |
| Q1 2025 | 14.8K | $1M | +1.27% |
| Q4 2024 | 11.0K | $1M | +1.05% |
| Q3 2024 | 11.4K | $1M | +1.17% |
| Q2 2024 | 12.0K | $1M | +1.42% |
| Q1 2024 | 12.3K | $2M | +1.49% |
| Q4 2023 | 12.4K | $1M | +1.33% |
| Q3 2023 | 16.7K | $2M | +1.47% |
| Q2 2023 | 15.9K | $2M | +1.82% |
| Q1 2023 | 19.7K | $2M | +1.96% |
| Q4 2022 | 20.8K | $2M | +2.04% |
| Q3 2022 | 20.2K | $2M | +1.75% |
| Q2 2022 | 21.0K | $2M | +1.78% |
| Q1 2022 | 16.8K | $1M | +1.23% |
| Q4 2021 | 16.6K | $1M | +1.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Weaver C. Barksdale & Associates, Inc.’s full portfolio or all institutional holders of MRK.